Comparison of clinical and pathological characteristics between screen-detected and self-detected breast cancers: a Hong Kong study
- PMID: 27022189
- DOI: 10.12809/hkmj154575
Comparison of clinical and pathological characteristics between screen-detected and self-detected breast cancers: a Hong Kong study
Abstract
Introduction: Breast cancer is the leading cause of death of Hong Kong women with increasing incidence. This study aimed to determine any prognostic differences between screen-detected and self-detected cases of breast cancer in a cohort of Hong Kong patients.
Methods: This was a case series with internal comparison carried out in a private hospital in Hong Kong. Approximately 3000 cases of Chinese patients diagnosed with ductal carcinoma in situ or invasive breast cancer were reviewed.
Results: The screen-detected group showed better pathological characteristics than the self-detected group. Number of lymph nodes involved, invasive tumour size, and tumour grade were more favourable in the screen-detected group. There was also a lower proportion of patients with pure invasive ductal carcinoma and mastectomy in the screen-detected group.
Conclusion: This study provides indirect evidence that women in the local population may gain clinical benefit from regular breast cancer screening. The findings need to be validated in a representative population of Hong Kong women.
Keywords: Breast neoplasms/diagnosis; Breast self-examination; Mammography.
Comment in
-
Mammography for breast cancer detection in Hong Kong.Hong Kong Med J. 2016 Jun;22(3):200-1. doi: 10.12809/hkmj164916. Hong Kong Med J. 2016. PMID: 27305694 No abstract available.
Similar articles
-
Ductal carcinoma in situ of breast: detection and treatment pattern in Hong Kong.Hong Kong Med J. 2017 Feb;23(1):19-27. doi: 10.12809/hkmj154754. Epub 2016 Oct 24. Hong Kong Med J. 2017. PMID: 27779099
-
The frequency of presentation and clinico-pathological characteristics of symptomatic versus screen detected ductal carcinoma in situ of the breast.Eur J Surg Oncol. 2014 Mar;40(3):249-54. doi: 10.1016/j.ejso.2013.12.013. Epub 2014 Jan 3. Eur J Surg Oncol. 2014. PMID: 24433818
-
Does breast screening offer a survival benefit? A retrospective comparative study of oncological outcomes of screen-detected and symptomatic early stage breast cancer cases.Eur J Surg Oncol. 2016 Dec;42(12):1814-1820. doi: 10.1016/j.ejso.2016.06.403. Epub 2016 Jul 9. Eur J Surg Oncol. 2016. PMID: 27424787
-
Optimal management of ductal carcinoma in situ of the breast.Surg Oncol. 2003 Dec;12(4):221-40. doi: 10.1016/S0960-7404(03)00031-8. Surg Oncol. 2003. PMID: 14998563 Review.
-
Treatment of ductal carcinoma in situ: an uncertain harm-benefit balance.Prescrire Int. 2013 Dec;22(144):298-303. Prescrire Int. 2013. PMID: 24600734 Review.
Cited by
-
Which type of cancer is detected in breast screening programs? Review of the literature with focus on the most frequent histological features.Pathologica. 2021 Apr;113(2):85-94. doi: 10.32074/1591-951X-123. Pathologica. 2021. PMID: 34042090 Free PMC article. Review.
-
Comparison of pathological characteristics between self-detected and screen-detected invasive breast cancers in Chinese women: a retrospective study.PeerJ. 2018 Apr 26;6:e4567. doi: 10.7717/peerj.4567. eCollection 2018. PeerJ. 2018. PMID: 29713563 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical